Navigation Links
Metastasis of Neuroblastoma linked to Loss Of Caspase-8 gene

The caspase-8 gene prevents the metastasis of the neuroblastoma. This research was conducted at St. Jude Children's Research Hospital and the University of California// at San Diego (UCSD).

Cancer cells that have broken itself from the main primary tumor have lost the function of this gene. Hence it is clear that caspase-8 gene is responsible for inhibiting metastasis.

Neuroblastoma is addressed to all tumors present in the nervous system. It is commonly seen in children at the age of one year. It forms about 10% of the childhood carcinomas.

When caspase-8 gene codes for the particular protein it always results in the metastasis of the tumor. The tumor is never present in the primary stage. In case of bringing back the functioning of the gene results in the containment of the spread of the tumor in the body.

The research is very important as it gives us an alternative in the treatment modalities of metastasizing neuroblastoma.

Integrins are molecules present on the surface of the cells including neuroblastoma. The main function of the Integrins molecule is that they anchor the cells with the extra cellular matrix.

Extra cellular matrix is the material present outside the cell, which gives structure to the tissue. When caspase-8 goes and binds to these Integrin molecules it triggers apoptosis.

But in case of tumor that is metastasizing the unbound Integrin molecules are free and when caspase-8 bind to it results in Integrin-mediated death (IMD). By this technique all the free and moving cancerous cells are destroyed by the Integrin molecules before they can affect another distant organ.

The research team conducted experiments using tumor cells and introducing them in the laboratory embryo models. When caspase-8 gene was blocked them the tumor cells began to spread to the lung and bone marrow.

When the neuroblastoma cells were implanted in the adult embryo models tumor metasta
'"/>




Page: 1 2

Related medicine news :

1. Understanding Lung Cancer Metastasis
2. Preventing Bone Metastasis In Patients With Breast Cancer
3. Researchers Identify Sipa 1 Gene, Responsible For Cancer Metastasis
4. New Model for understanding Tumor Metastasis
5. Breast Tumor Metastasis Stimulated by Post Pregnancy Circumstances
6. Gene That Causes Metastasis of the Primary Tumor, Identified
7. Gene Responsible For Metastasis Found By Korean Scientists
8. Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated
9. Cancer cell behavior during Metastasis – New finding
10. Radiofrequency Ablation Useful in Treating Ovarian Cancer Metastasis
11. "Trojan Horse" Agent Halts Bone Metastasis in Mice

Post Your Comments:
(Date:11/9/2009)... The award-winning docume...ision debut on the Sundance Channel on World Diabe... Directed by Academy Award® nominee Edward La...ith type 1 diabetes amid the verdant mountains and...t countries. The children are supported with life-...
(Date:11/9/2009)...9 Speaker Nancy Pelosi...ons in the Affordable Health Care for America ...id and reduce Medicare Part D costs for people liv...aturday by a vote of 220 to 215: ,, "Effective...lity of life for thousands of Americans living wit...
(Date:11/9/2009)...rt Experimental Procedure for Preteen Son - ,...For parents of children with cancer, the hopeful n... improved for decades. Among the bad news -- treat.... ,, Boys diagnosed with cancer who have reac...rve their fertility: before undergoing cancer trea...
(Date:11/9/2009)...l use funds to move lab findings into human therap...ain from nerve damage ,, ANN ARBOR, Mich., Nov... University of Michigan Department of Neurology ha...l therapy for neuropathic pain, a difficult-to-tre...ause of damage to nerve without obvious tissue inj...
(Date:11/9/2009)...r 9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), th...y announced the availability of INTUNIV (guanfacin...he United States for the treatment of Attention-De...d adolescents ages 6 to 17. INTUNIV, a once-daily...nonscheduled alpha-2A receptor agonist approved fo...
Breaking Medicine News(10 mins):Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
...mail intervention program is an effective way to s... helping people move more, sit less, and make heal...te Division of Research study in the American Jou...g 787 Kaiser Permanente Northern California employ...
...cancer bringing total raised by LIFE to $5.6 milli...ros including World Golf Hall of Fame members Beth... Stanford, Morgan Pressel, Brittany Lincicome, Hel...ast Cancer) Event hosted by LPGA veteran Val Skinn...
...ewswire-Asia-FirstCall/ -- BMP Sunstone,Corporatio...y"), today announced,financial results for the fir...Highlights from the First Quarter Ended March 31, ....7 million from $7.7 million in the prior, y...
...es, Inc. (Nasdaq: GTIV ), a leading provider of ... that on May 14, 2009 it received official notific...ce with the exchange,s independent director requir...ows: , , , until the earlier of the Com...
...ls, Inc. (Nasdaq: TRBN ) announced today that da...dy (15002) of TRU-015 for rheumatoid arthritis wil...gue Against Rheumatism (EULAR) annual meeting in C...TRUBIONLOGO ) , , Data from the first course of r...
...y Corporation, (Nasdaq: QG L Y), www.quigley...any,s possible alternative strategies going forwar...rding the unexpected positive finding for its QR-3...al are awaited, the Company,s Board of Directors a...
Other Medicine News:Health News:Workplace e-mail intervention program helps people sit less and eat better 2Health News:Workplace e-mail intervention program helps people sit less and eat better 3Health News:LIFE 10th Anniversary Event Delivers Big Names and Big Dollars for Breast Cancer Fight 2Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 2Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 3Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 4Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 5Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 6Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 7Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 8Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 9Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 10Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 11Health News:Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement 2Health News:Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement 3Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 2Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 3Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 4Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 2Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 3Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 4
(Date:11/9/2009)...., Nov. 9 Anesiva, Inc. ...5, 2009, it received a letter from The NASDAQ Stoc...aring Panel has granted Anesiva,s request for cont...to the condition that Anesiva shall have completed...er (the "Merger") contemplated by the Agreement an...
(Date:11/9/2009)...PRNewswire-FirstCall/ -- Caliper Life Sciences, In...nd services for drug discovery and life sciences r...y Alliances and Services (CDAS) unit has been awar...r its contract with the Environmental Protection A...m. This new task order increases the cumulative f...
(Date:11/7/2009)... Most patients with hereditary angi...n oncoming HAE attack giving the patients sufficie...bidity associated with that attack, according to s...n College of Allergy, Asthma & Immunology (ACA...such as fatigue and nausea, which occur frequently...
Breaking Medicine Technology:Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Caliper Awarded New Task Order for EPA ToxCast Program 2Caliper Awarded New Task Order for EPA ToxCast Program 3Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3Chicago Hispanic Health Coalition Presents Third Annual Vive tu Vida 21 Get Up 21 Get Moving 21 28TM 29 Event 49009 1Chicago Hispanic Health Coalition Presents Third Annual Vive tu Vida 21 Get Up 21 Get Moving 21 28TM 29 Event 49009 2Sunesis to Present at the Jefferies 3rd Annual Healthcare Conference 12643 1Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 4598 1Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 4598 2Study Demonstrates Efficacy of Pitavastatin in Elderly Patients 4598 3
... China, Sept. 3 Simcere,Pharmaceutical Group (NYS...branded generic pharmaceuticals and manufacturer o...lso known as Endostar) in China,announced the inte...the request of the SFDA, Simcere initiated a Phase...and therapeutic efficacy of Endu, a modified,versi...
...BURG, Md., Sept. 3 Panacea Pharmaceuticals,Inc. t...7,413,737 covering,antibodies against human aspart...etary human cancer biomarker and therapeutic targe...n with the Massachusetts Institute of,Technology (...o this patent,for development of human cancer diag...
Other Medicine Technology:Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4
MBS Thermal Cycler 1 Block Start Up Kit
...Thermal Cycler (PxE) is a licensed 96 well PCR mac...s for value for money thermal cycling. It is buil...rience in manufacturing and retains a high level o... other products in the range. The combination of ...
MyCycler Thermal Cycler
GeneAmp PCR System 2700
Medicine Products: